StockNews.com initiated coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a report released on Friday morning. The brokerage issued a sell rating on the stock.
Ayala Pharmaceuticals Stock Performance
Shares of ADXS stock opened at $0.02 on Friday. The company has a market capitalization of $852,600.00, a price-to-earnings ratio of 0.00 and a beta of 1.56. The company has a 50-day simple moving average of $0.10 and a 200 day simple moving average of $0.38. Ayala Pharmaceuticals has a 52 week low of $0.00 and a 52 week high of $1.49.
Ayala Pharmaceuticals Company Profile
Featured Articles
- Five stocks we like better than Ayala Pharmaceuticals
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Don’t Overlook Campbell Soup: Here’s What Could Drive Its Stock
- Insider Buying Explained: What Investors Need to Know
- Birkenstock’s Sudden Slide—Why It Might Be Your Next Big Win
- Investing In Automotive Stocks
- MarketBeat Week in Review – 8/26 – 8/30
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.